ETON — Eton Pharmaceuticals Share News
0.000.00%
Last trade - 00:00- $1.43bn
- $1.43bn
- $79.95m
Aquestive rises on US licensing deal for seizure drug with Eton Pharma
U.S. STOCKS ON THE MOVE-Sun Communities, Cisco Systems, Paysafe
U.S. STOCKS ON THE MOVE-Fox, Sun Communities, Reddit, drone firms
U.S. STOCKS ON THE MOVE-Boost Run, Nektar Therapeutics, Swarmer
U.S. STOCKS ON THE MOVE-Reddit, Capricor Therapeutics, Birkenstock
Eton Pharmaceuticals rises on Q2 profit beat
Eton Pharmaceuticals Inc reports results for the quarter ended June 30 - Earnings Summary
Refile: Eton Pharmaceuticals Q2 adjusted EPS beats estimates, revenue up 99% on HEMANGEOL relaunch
Eton Pharmaceuticals Inc expected to post earnings of 11 cents a share - Earnings Preview
Brief: Eton Pharmaceuticals Expands Infantile Hemangioma Franchise
U.S. RESEARCH ROUNDUP-IBM, MSCI, US Bancorp
Eton Pharma rises after securing US rights for rare disease drug
Eton Pharmaceuticals Q1 product sales rise driven by portfolio expansion
Brief: Eton Pharmaceuticals Q1 Net Income USD 1.554 Million
Eton Pharmaceuticals beats Q4 adjusted EPS estimates
NASDAQ RESUMED AT 02:15 PM
US FDA approves Eton Pharma's hormonal disorder drug (updated)
US FDA approves Eton Pharma's hormonal disorder drug
NASDAQ TRADE HALT HALT NEWS PENDING AT 12:33 PM